Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterile alpha motif domain-containing protein 11 (SAMD11) is an evolutionarily conserved protein that functions as a transcriptional co-repressor through its role in Polycomb repressive complex 1 (PRC1)-like complexes, especially in retinal photoreceptor cells. It is predominantly expressed in developing and mature rod photoreceptors, where it interacts with other SAM-domain proteins to help maintain photoreceptor cell identity by repressing nonrod gene expression. In humans, SAMD11 also shows a broader tissue distribution and is involved in negative regulation of transcription mediated by RNA polymerase II. Mutations in SAMD11 are associated with retinal degenerative diseases such as retinitis pigmentosa, and the gene has also been implicated in neurodevelopmental disorders and cancer progression (through its circular RNA form, circSAMD11). No approved drugs are known to target SAMD11, nor is it a current focus for therapeutic intervention, but it may serve as a biomarker or research target for disease mechanisms involving epigenetic regulation and cell identity maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterile alpha motif domain-containing protein 11 (SAMD11).